
NYSE:MOH
This summary was created by AI, based on 1 opinions in the last 12 months.
Molina Healthcare (MOH-N) has experienced a significant decline of 55% over the past year, raising concerns about its performance in the market. This sharp drop is compounded by the company's heavy reliance on Medicare and Medicaid, which makes it vulnerable to changes in government healthcare policies and funding. The stock is also set to leave the S&P index, adding to worries among investors regarding its stability and growth prospects. While the company's focus on healthcare services for underserved populations is commendable, the risks associated with its revenue sources significantly overshadow its potential for recovery in the near term. Investors may need to approach Molina with caution considering these factors.
Molina Healthcare is a American stock, trading under the symbol MOH (previously MOH-N on Stockchase) on the New York Stock Exchange (MOH). It is usually referred to as NYSE:MOH or MOH
In the last year, 1 stock analyst issued a Buy, Sell, or Hold rating on MOH (previously MOH-N on Stockchase). 0 analysts recommended to BUY and 1 analyst recommended to SELL the stock. The latest stock analyst rating is DON'T BUY. Read the latest stock experts' ratings for Molina Healthcare.
Molina Healthcare was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Molina Healthcare.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Molina Healthcare.
Molina Healthcare is covered by Stockchase experts and is worth watching.
On 2026-08-13, Molina Healthcare (MOH) stock closed at a price of $205.71.
Is -55% the past year. Very exposed to Medicare and Medicaid. Is leaving the S&P.